[Position paper on the use of drug eluting stents in coronary heart disease].
Mudra
H
H
Krankenhaus Neuperlach, II. Med. Abteilung, Oskar-Maria-Graf-Ring 51, 81737 Munich, Germany. h.mudra@kh-neuperlach.de
Bode
C
C
Grube
E
E
de Haan
F
F
Levenson
B
B
Schuler
G
G
Silber
S
S
D001807:Blood Vessel Prosthesis / Q000009:adverse effects*; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy* / Q000601:surgery*; D023903:Coronary Restenosis / Q000209:etiology / Q000517:prevention & control*; D016503:Drug Delivery Systems / Q000295:instrumentation / Q000379:methods; D005858:Germany; D006083:Graft Occlusion, Vascular / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D010346:Patient Care Management / Q000379:methods; D017410:Practice Guidelines as Topic; D012955:Societies, Medical; D015607:Stents / Q000009:adverse effects*
D007166:Immunosuppressive Agents